The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

This is just a sneak peek at the thousands of consumer insights available to CivicScience clients. Discover more data. The ...

The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper ...

New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health ...

GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...

Ozempic, a diabetes medication by Novo Nordisk, has gained popularity for its weight loss effects, sparking debate.

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

New popular weight-loss and anti-diabetes drugs may reduce the rate of opioid overdose or alcohol intoxication in people with ...

Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, ...